-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology Holdings Q3 Adj. EPS $(0.36) Beats $(0.37) Estimate

Benzinga·11/07/2025 13:17:16
Listen to the news
ALX Oncology Holdings (NASDAQ:ALXO) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.37) by 1.91 percent. This is a 20 percent increase over losses of $(0.45) per share from the same period last year.